Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 5/2002

01-07-2002 | Original Article

Isometric strength measurement for muscle weakness in cancer patients

Reproducibility of isometric muscle strength measurements with a hand-held pull-gauge dynamometer in cancer patients

Authors: Ruud H. Knols, Karel H. Stappaerts, Jaap Fransen, Daniel Uebelhart, Geert Aufdemkampe

Published in: Supportive Care in Cancer | Issue 5/2002

Login to get access
Metadata
Title
Isometric strength measurement for muscle weakness in cancer patients
Reproducibility of isometric muscle strength measurements with a hand-held pull-gauge dynamometer in cancer patients
Authors
Ruud H. Knols
Karel H. Stappaerts
Jaap Fransen
Daniel Uebelhart
Geert Aufdemkampe
Publication date
01-07-2002
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 5/2002
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-002-0343-6

Other articles of this Issue 5/2002

Supportive Care in Cancer 5/2002 Go to the issue

Review Article

Bisphosphonates for cancer patients: why, how, and when?

Original Article

What do patients living with advanced cancer and their carers want to know? – A needs assessment

Original Article

Outcome and cost implications of cardiopulmonary resuscitation in the medical intensive care unit of a comprehensive cancer center

Review Article

Fatigue associated with cancer and its treatment

Letter to the Editor

Anthropometric measurements in non-small-cell lung cancer

Editorial

Do patients with advanced cancer get appropriate information?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits